GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (LTS:0A05) » Definitions » ROE % Adjusted to Book Value

Medacta Group (LTS:0A05) ROE % Adjusted to Book Value : 3.17% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group ROE % Adjusted to Book Value?

Medacta Group's ROE % for the quarter that ended in Dec. 2024 was 19.01%. Medacta Group's PB Ratio for the quarter that ended in Dec. 2024 was 5.99. Medacta Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 3.17%.


Medacta Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Medacta Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group ROE % Adjusted to Book Value Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.13 2.36 1.91 3.41

Medacta Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.01 2.45 1.42 3.08 3.17

Competitive Comparison of Medacta Group's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Medacta Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Medacta Group's ROE % Adjusted to Book Value falls into.


;
;

Medacta Group ROE % Adjusted to Book Value Calculation

Medacta Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=20.44% / 5.99
=3.41%

Medacta Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=19.01% / 5.99
=3.17%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medacta Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Medacta Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Medacta Group Business Description

Traded in Other Exchanges
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions.

Medacta Group Headlines

No Headlines